India’s COVID-19 testing strategy will help control future spurt of infection: GlobalData

first_img Comments (0) Read Article Add Comment By EH News Bureau on November 19, 2020 Phoenix Business Consulting invests in telehealth platform Healpha Share Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Related Posts India’s COVID-19 testing strategy will help control future spurt of infection: GlobalData  Adoption of AI/ML can disrupt healthcare services WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals The missing informal workers in India’s vaccine story COVID-19 testing capacityGlobalData India has the third-highest cumulative testing after China and US, but per million testing still less than developed countriesAs several countries go through a second wave of COVID-19 infection, India, ranked second in confirmed COVID-19 cases globally, has drastically ramped up its COVID-19 testing capacity, which will help it control future spurts of infection or future waves, according to GlobalData.India reached the two million overall testing milestone on May 14, 2020, achieved the one million daily testing milestone on August 21 and now has the capacity to conduct 1.5 million daily tests. As of November 17, the country conducted more than 120 million tests, the third-highest cumulative testing after China and the US. However, India’s per million testing stands at more than 91,000, which is still less than developed countries.According to GlobalData’s ‘Coronavirus Disease (COVID-19) Pharma Executive Briefing – November 10, 2020’, India conducted more than 7.8 million tests between November 3-10, which is highest among all countries for that timespan.Prashant Khadayate, Pharma Analyst at GlobalData, comments, “India is relying on testing as a crucial tool to control the spread of infection as part of its Test, Track, and Treat strategy for early identification of cases and to limit transmission to others. With enhanced testing, India’s overall positivity rate is also decreasing, which clearly shows that testing will play a crucial role until vaccines are available.”According to GlobalData’s COVID-19 dashboard, as of November 17, 2020, India has 8,845,127 confirmed cases, and the dashboard forecasts 33,473,349 confirmed cases in a low transmission risk scenario by November 29.Testing is being focused on symptomatic individuals, symptomatic or asymptomatic and high-risk contacts (in family and workplace, elderly ≥ 65 years of age, immunocompromised, those with co-morbidities, etc.) of laboratory-confirmed cases.Khadayate concludes, “Considering the start of winter and festival season, India should be well-prepared to face rapid growth in the spread of COVID-19 or a second wave of infection. It is pleasing that India has already ramped up daily testing capacity, which will really help it to contain the infection to the best possible extent.” MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” COVID-19 Updates Health policies Lab Diagnostics News Menopause to become the next game-changer in global femtech solutions industry by 2025last_img

Posts Tagged with… , , , , , , , , , , ,

Write a Comment

Your email address will not be published. Required fields are marked *